Brown University alum Dr. Myechia Minter-Jordan leads AARP, follows Jo Ann Jenkins

Published in RINewsToday on November 18, 2024

With AARP Chief Executive Officer (CEO) Jo Ann Jenkins announcing her decision eight months ago in a statement by Lloyd Johnson, Chair of AARP Board of Directors, he pledged that his Board would move “diligently to find the right person to lead AARP on the next leg of its journey.”  The Board supported by Heidrick and Struggles, an international executive search and management consulting company headquartered in Chicago, Illinois, recruited Dr. Myechia Minter-Jordan to serve as its next CEO.

Minter-Jordon, 52, a physician and former president and CEO of CareQuest Institute for Oral Health, a nonprofit group that promotes dental health, will oversee 21 departments at the Washington, DC-based AARP, which has state affiliates in all 50 states, as well as the District of Columbia, Puerto Rico, and the Virgin Islands.  According to Forbes, as of February 2024, AARP had 2,250 employees and was ranked No. 31 in its America’s Best Midsize Employers listing.  The Paddock Post reported that the organization’s total revenue in 2022 was $ 1.8 billion.

Leading AARP into the Future

“Dr. Minter-Jordan joins us with the necessary attributes to successfully guide AARP on the next leg of our journey to help people live better as they age,” says AARP’s Board Chair Johnson in a Nov. 12 statement announcing her hiring. “She is an accomplished physician and innovative business leader who brings to AARP a strong passion for our social mission, demonstrated ability to balance strategic decisions with financial discipline, build strong teams, foster collaboration and lead organizations through rapid change and growth. We’re thrilled to have her leading the fight for what matters most to older Americans during this time of increasing social and technological change,” he says.

According to AARP, prior to Minter-Jordan’s new role at AARP, she served as President and CEO (2021-2024) of CareQuest Institute for Oral Health. As a physician and business executive, she played a key role in advising and shaping strategic initiatives aimed at improving dental health care outcomes through advocacy, policy development, and philanthropic efforts. In the spring of 2024, she testified before the Senate Committee on Health, Education, Labor, and Pensions (HELP) about the dental care crisis in America.

Before joining CareQuest Institute, Minter-Jordan’s bio noted that she served as chief medical officer and CEO of the Dimock Center, one of the largest community health centers in Massachusetts. During that time, Dimock was recognized as a national model for comprehensive, integrated health and human services.

AARP’s new exec was also active as a Board member to an array of nonprofits.  She served on several boards and committees at BlueShield of California, the Yawkey Foundation, Penn Dental Medicine, the Isabella Stewart Gardner Museum, and board emeritus at The Boston Foundation, and Point32 Health. Previously, she held appointed positions at agencies including the Massachusetts Health Planning Council Advisory Committee and the City of Boston Public Health Commission.

Once a Rhode IslanderBrown grad

Minter-Jordan once called Rhode Island her home. She earned both her undergrad degree and doctor of medicine degree from Brown University School of Medicine and a master of business administration degree from Johns Hopkins University Carey School of Business. She also received honorary doctorates from Northeastern University and Newbury College.

“This is a pivotal moment for AARP and the nation,” says Minter-Jordan, noting that for more than 65 years, the nonprofit has been instrumental in improving the lives of older Americans by “helping people age on their own terms and live their lives to the fullest.” 

“As AARP looks ahead, we have exciting opportunities to empower, uplift and make a positive impact on the health, wealth and wellness of the more than 110 million Americans ages 50 and older and the entire country,” she says.

Jenkins’ farewell to AARP

Jo Ann Jenkins

On March 21, 2024, AARP CEO Jo Ann Jenkins, 66, announce her decision to step down when her contract expired at the end of the year.  She began her long-time relationship with AARP in 2004 when she joined the AARP Services, Inc. (ASI) Board of Directors. She served as ASI’s Chair from 2009 to 2010.  In 2010, she became President of AARP’s Foundation, and three years later became AARP’s Executive Vice President and later its CEO.

With the announcement of her departure, AARP Board Chair Johnson recognized her “impressive record of accomplishments in advancing AARP’s mission and serving our members.”   He added, “Jo Ann has led AARP on a transformational journey to redefine the organization’s vision, challenge outdated attitudes and stereotypes about aging, and spark innovative solutions that empower people to choose how they live as they age.”

Among the accomplishments during her tenure, Jenkins championed the multi-generational workforce, healthy longevity, protecting Social Security and Medicare, and lowering the cost of prescription drugs. She has led through a spirit of innovation, creating AgeTech and launching a Digital First journey to help AARP better serve our members in the future.

Under Jenkins leadership, AARP has received the Malcolm Baldrige National Quality Award, has been recognized by Ethisphere as one of the World’s Most Ethical Companies, has been named as one of Fast Company magazines Best Workplaces for Innovators, and for the past seven years has been named as a Washington Post Best Workplace. In 2019 and 2021, Fortune magazine named her as “One of the World’s 50 Greatest Leaders.” Her national best-selling book, Disrupt Aging: A Bold New Path to Living Your Best Life at Every Age, became a signature rallying cry for revolutionizing society’s views on aging.

A fond farewell

In a “Farewell to AARP” posted on the nonprofit’s Advocacy webpage on Nov. 6, 2024, Jenkins reflected on her first speech as AARP’s CEO at an AARP national member event at the San Diego Convention Center.

“That day I made a promise to AARP’s members: “As your CEO, I will be unapologetic in fighting for the wants and needs of people 50-plus. As AARP’s new CEO, I wanted to change the conversation about what it means to grow older. I said we need to “disrupt aging”—to challenge outdated stereotypes and attitudes about getting older and spark new solutions that help people live better as they age. I challenged our members to help me do that,” she recalled.

“We changed not just the conversation about aging but also what it means to grow older,” she stated in that posting. And she concluded, “As I wind up my tenure as the steward of the legacy of our founder, Dr. Ethel Percy ­Andrus, I’m proud that we have lived up to the motto she gave us more than 65 years ago — ‘To serve; not to be served.’ I leave confident that AARP is well positioned to continue building on that legacy.”

“Serving as your CEO has been a tremendous privilege and extraordinary experience. What I will miss the most is you, the members and volunteers, and the exceptional staff whose passion for our mission and commitment to service is second to none,” said in her swan song posting.

“As I bid you farewell, I want to thank you from the bottom of my heart for your support, your service and all you do to disrupt aging,” she added, noting that while leaving AARP, “rest assured that I will continue to be unapologetic in fighting for the wants and needs of people 50-plus.”

Jenkins has surely made her mark as the nation’s top advocate.  She leaves AARP in Minter-Jordan’s capable hands.  Good luck to both of you.

Cap on out— of-pocket costs for Medicare drug plan enrollees coming soon

Published in RINewsToday on September 2, 2024 

Back on Aug. 16th in 2022, President Joe Biden signed into law the Inflation Reduction Act of 2022 (IRA), it’s enactment lowering the health cost for millions of older Americans by lowering the high cost of prescription drugs by granting Medicare the power to directly negotiate drug prices with drug companies.  Rising drug costs were forcing some Medicare beneficiaries to cut their expenses by not filling a prescription or even skipping doses. This could lead to complications and side effects resulting in hospitalization, even death.

“AARP was instrumental in Congress passing the prescription drug law of 2022 to lower prices and out-of-pocket costs for Medicare enrollees,” said Jo Ann Jenkins, CEO of AARP in an Aug. 28 statement announcing the release of AARP’s new report. “As we approach January 2025, we want every senior in America to know that, thanks to the new annual cap which limits their out-of-pocket costs, they will have more money to invest in their families, spend on their broader health needs or simply save to achieve greater financial stability.”

Virtual Media Briefing Details Impact on IRA law

Last week, the Washington, DC-based AARP briefed the media on the state-level impact of the historic new federal protection for 56 million Medicare drug plan enrollees. The new law caps out-of-pocket prescription drug costs every year, beginning at $2,000 in January 2025. 

The nine-page Public Policy Institute report, released at the virtual media briefing, analyzes the number of enrollees (not receiving the Medicare low-income subsidy) that will benefit from the new cap by state, age, gender, and race between 2025 and 2029.

Nancy LeaMond, the chief advocacy and engagement officer for AARP, say putting the brakes to spiraling drug cost by enacting the IRA put money back into the pockets of millions of America’s retirees purchasing pharmaceuticals for their medical conditions. “Upwards of 95% of Americans, age 65 and older, have at least one chronic condition and close to 80% are dealing with 2 or more chronic conditions,” says LeaMond, like diabetes and heart disease, to debilitating neurological diseases like Parkinson’s and Ms.

“Prescription drugs are a lifeline, said LeaMond, stressing that medicine is only effective if you have the money to pay for it. The passage of IRA two years ago is already having a significant and positive impact on millions of Medicare beneficiaries who now don’t pay more than $35 a month for insulin and get free vaccines for things like shingles,” she noted. 

“There are even bigger savings coming down the pike, starting in January 2025. The total amount that folks enrolled in Medicare drug plans pay out of pocket for their prescriptions will be capped at $2,000 a year,” reports LeaMond.  

During the media briefing, Leigh Purvis, Prescription Drug Policy Principal, AARP Public Policy Institute, stated “one of the biggest challenges in the original Medicare Part D benefit was the lack of a cap on out-of-pocket spending.”  Even after reaching a certain limit, Medicare beneficiaries were still required to pay 5% of their drug costs, with no limit for those on expensive Medications, she said.

According to Purvis, out of pocket expenses could exceed $10,000 per year, “an unmanageable amount for anyone, but especially for a population with a Median annual income of $36,000. Because of this, AARP pushed for the inclusion of a cap on out-of-pocket spending for Medicare Part D, to be included in the IRA, she said.  And it was…

Purvis noted that 3 million Part D beneficiaries (who don’t receive the Medicare Part D low-income subsidy are expected to benefit from the $2,000 cap in 2025.  This number is expected to grow to over 4 million by 2029.  These Medicare drug plan enrollees would see average savings of roughly $1,100, or 56%, in 2025 for their prescription drugs. 

Purvis also gave a few other takeaways from the report.  On average,  approximately 1.4 million (40 percent) Medicare drug plan enrollees who reach the new out-of-pocket cap between 2025 and 2029 are estimated to see annual savings of $1,000 or more, and just over 420,000 (12 percent) will see savings of more than $3,000.  In addition, more than three-quarters of Medicare drug plan enrollees who will benefit in 2025 are between the ages of 65 and 84.

Finally, Paula Cunningham, AARP Michigan State Director (discussing  results of a state survey) and Diana Devito , who has lived with chronic lymphocytic leukemia for over 19 years, participated in the media briefing. Both reinforced  how the report’s numbers aren’t just statistics, they represent real people “who are being forced to make impossible choices.” 

Cunningham told a “heartbreak” story about a woman who had lost her husband, and she had to sell her wedding ring in order to pay for her prescription drugs. “She’s now deceased, but I will never forget her story, or the stories of people across this great state that we met who had to make difficult choices between paying rent or buying groceries to pay for their medications,” she said.

After experiencing the high prescription costs for treating life-threatening chronic disorder, Devito came to share how important a $2,000 cap can be “for people like me.”  She said, “It’s a real-life changer,” noting that everyone doesn’t understand that. “If you’re not taking one of these expensive drugs, you don’t realize the impact that it has on your life,” she added.

On Another Note…

U.S. Senator Jack Reed brings to my attention another Congressional report that details the Rhode Island specific data as to the impact of IRA on older Rhode Islanders.

According to the Congressional Joint Economic Committee (CJEC), this year, about 57,000 Rhode Island Medicare beneficiaries will save an average of roughly $200 each year because of IRA’s improvement to the Medicare Part D drug coverage. By 2025 this number would increase to 68,000 retirees, saving them an annual average of $340 on prescription drugs.

By allowing Medicare to negotiate with drug companies to bargain down the high cost of many lifesaving drugs, 29,000 retirees use drugs that are with the new negotiated prices, says the CJEC report.

For a copy of AARP Public Policy Institute’s Medicare Part D Out-of-Pocket Spending Cap, go to https://www.aarp.org/pri/topics/health/prescription-drugs/medicare-part-d-out-of-pocket-spending-cap-prescription-drug-costs/.

To learn more about AARP’s work to lower prescription drug prices, visit https://www.aarp.org/politics-society/advocacy/prescription-drugs/.

For a copy of CJEC’s report, go to https://www.jec.senate.gov/public/_cache/files/356ae3d2-af5e-4d32-bd42-fafc548173c5/ri-cost-savings-fact-sheet.pdf

For details how the IRA impacts older Rhode Island retirees, go to https://www.whitehouse.gov/wp-content/uploads/2022/08/Rhode-Island-Health-Care.pdf

Modest Social Security COLA increase seen as chump change by some

Published in RINewsToday on October 16, 2023

Last week, the Social Security Administration (SSA) announced that Social Security and Supplemental Security Income (SSI) benefits for more than 71 million beneficiaries will increase 3.2% in 2024, about $59 per month starting in January. The 2024 payment declined from last year’s 8.7%, but that had been the highest in four decades. And, its higher than the average 2.6% increase recorded over the past 20 years.

The Social Security Act determined how the cost-of-living adjustment (COLA) is calculated. Enacted on August 14, 1935, the Act ties the annual COLA to the increase in the Consumer Price Index for Urban Wage Earners and Clerical Workers (CPI-W) as determined by the Department of Labor’s Bureau of Labor Statistics.

More than 66 million Social Security beneficiaries will see that COLA increase 3.2% beginning in January 2024, and increased payments to approximately 7.5 million people receiving SSI will begin on December 29, 2023. (Note: some people receive both Social Security and SSI benefits).  

“Social Security and SSI benefits will increase in 2024, and this will help millions of people keep up with expenses,” observes Kilolo Kijakazi, Acting Commissioner of Social Security in an Oct. 12 statement announcing this year’s COLA increase.

According to SSA, some other adjustments that will also take effect in January of each year are based on the increase in average wages. Based on that increase, the maximum amount of earnings subject to the Social Security tax (taxable maximum) will increase to $168,600 from $160,200.

Advocacy groups on aging talk turkey about COLA

“The annual COLA is a reminder of Social Security’s unique importance. Unlike private-sector pension plans, whose benefits erode over time, Social Security is designed to keep up with rising prices, noted Nancy Altman, President of the Washington, DC-based Social Security Works (SSW), in response to SSA’s COLA announcement.  

“Retirees can rest a little easier at night knowing they will soon receive an increase in their Social Security checks to help them keep up with rising prices,” said Jo Ann Jenkins, AARP chief executive. “We know older Americans are still feeling the sting when they buy groceries and gas, making every dollar important,” she added, stressing that Social Security has been the foundation for financial security for hundreds of millions of retirees. “SSA’s COLA announcement shows that it’s continuing to deliver on this promise,” she says.  

However, Max Richtman, President and CEO, National Committee to Preserve Social Security and Medicare charges, “While we are grateful that Social Security is the only major retirement program with a built-in cost-of-living adjustment, the current formula for determining COLAs is inherently flawed. SSA’s current COLA formula doesn’t truly reflect the increase in prices for the goods and services that beneficiaries rely on.”

According to Richtman, the 3.2% 2024 COLA only represents a modest $59 increase in the average monthly benefit for retired workers, and that’s before deducting the projected increase in the 2024 Medicare Part B premium of about $10 per month. Because of this the average retirement beneficiary will receive a net COLA of about $50. 

Richtman notes, “That is not enough for a tank of gas or half a week’s worth of groceries in many states. The net COLA will barely cover one brand-name prescription co-pay for some patients.”  

Last year, Richtman noted that the COLA of 8.7% was unusually high, the highest in some 40 years. But post-pandemic inflation was also at record highs, he said, noting that historically, COLA’s have been relatively low. In fact, the COLA has been ZERO; three times since 2009.  

“Seniors deserve an accurate COLA formula that accounts for the impact of inflation on their living costs. That is supposed to be the entire purpose of a COLA. The current formula measures the impact of inflation on urban wage earners and clerical workers. How is that a reasonable formula for seniors? Seniors have different spending patterns than urban wage earners & clerical workers,” asks Richtman.  

Richtman notes that seniors spend more than other age group on expenses like housing, long-term care, and medical services. “We strongly favor the adoption of the CPI-E (Consumer Price for the Elderly) for calculating COLAs. The CPI-E would more accurately reflect the impact of inflation on the goods and services seniors need, he believes. 

The CPI-E is included in both major pieces of legislation to expand and protect Social Security that have been introduced in this Congress: Bernie Sanders’ Social Security Expansion Act and Rep. John Larson’s Social Security 2100 Act.  We have endorsed both of those bills as part of our commitment to boosting Social Security for current and future retirees. It’s past time for Congress to act,” says Richtman. 

Although the 3.2% COLA is well above the 2.6% average over the past 20 years, a newly released retirement survey released on Oct. 12, 2023, by The Senior Citizens League (TSCL) indicates that seniors are pessimistic about their financial well-being in the upcoming months and very concerned about growing calls on Capitol Hill for Social Security cuts. Sixty-eight percent of survey participants report that their household expenses remain at least 10 percent higher than one year ago, although the overall inflation rate has slowed. This situation has persisted over the past 12 months.

According to TSCL’s latest retirement survey, worry that retirement income won’t be enough to cover the cost of essentials in the coming months is a top concern of 56 percent of survey respondents. Social Security benefit cuts are an even bigger concern, ranked as the number one worry by nearly 6 out of 10 survey participants, or 59%. Over the past year, benefit cuts and trims have affected a large percentage of older Americans low-income households, individuals who can least afford them.

A year ago, TSCL warned that higher incomes due to the 5.9% and 8.7% COLAs in 2022 and 2023 could potentially affect eligibility for low-income assistance programs such as SNAP and rental assistance. Earlier this year, federal emergency COVID assistance for SNAP (food stamps) and Medicaid also ended. Surveys conducted in 2022 and this year suggest that significant numbers of lower-income older households have lost access to some safety net programs over the past 12 months, the survey finds.

A Final Note…

Social Security plans to start notifying beneficiaries about their new COLA amount by mail starting in early December. Individuals who have a personal “my Social Security account” can view their COLA notice online, which is secure, easy, and faster than receiving a letter in the mail. People can set up text or email alerts when there is a new message–such as their COLA notice—instead of waiting for them in my Social Security.

People will need to have a “my Social Security account” by November 14 to see their COLA notice online. To get started, visit www.ssa.gov/myaccount.

Information about Medicare changes for 2024 will be available at www.medicare.gov. For Social Security beneficiaries enrolled in Medicare, their new 2024 benefit amount will be available in December through the mailed COLA notice and my Social Security’s Message Center.

For details about SSA’s 2024 Changes, go to: https://www.ssa.gov/news/press/factsheets/colafacts2024.pdf.